Adding the PARP inhibitor olaparib to bevacizumab maintenance therapy for ovarian cancer among patients who have responded to platinum-taxane chemotherapy improves outcomes regardless of when surgery took place, according to an...
In the past, we as physicians have not done a great job of advocacy, and we have largely been removed from policy discussions. The emergence of physician advocacy is a relatively new phenomenon. Why? … Read Full Article...
After 8 hours of back-to-back virtual engagement with parents, I found myself with a kind of telemedicine fatigue that’s hard to describe. I’m going to continue to dig deeper into this, but I suspect that it represents a couple...
Findings seen in a national sample of Dutch patients from 1991 to 2015
Algorithm helps identify which patients can be offered fertility-sparing treatment options Using the Proactive Molecular Classifier for endometrial cancer (ProMisE) algorithm to classify patients with endometrial cancer or...
